SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Smiths Food & Drug Centers Inc – ‘10-K’ for 1/1/94 – EX-10.9

As of:  Monday, 3/28/94   ·   For:  1/1/94   ·   Accession #:  850309-94-3   ·   File #:  1-10252

Previous ‘10-K’:  None   ·   Next:  ‘10-K’ on 3/30/95 for 12/31/94   ·   Latest:  ‘10-K/A’ on 8/6/97 for 12/28/96

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size

 3/28/94  Smiths Food & Drug Centers Inc    10-K        1/01/94   10:352K

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Form 10K for Year Ended January 1, 1994               19±    92K 
 6: EX-10.11    Material Contract                                      7±    29K 
 7: EX-10.17    Material Contract                                     53±   230K 
 2: EX-10.3     Material Contract                                      1      8K 
 3: EX-10.6     Material Contract                                     36±   132K 
 4: EX-10.8     Material Contract                                      2±    10K 
 5: EX-10.9     Material Contract                                      9±    38K 
 8: EX-13.1     Annual or Quarterly Report to Security Holders        18±    79K 
 9: EX-22.1     Published Report Regarding Matters Submitted to a      1      5K 
                          Vote of Security Holders                               
10: EX-23.1     Consent of Experts or Counsel                          1      7K 


EX-10.9   —   Material Contract



Smith's Food & Drug Centers, Inc. Page 4 EXHIBIT 10.9 October 15, 1993 SMITH'S FOOD & DRUG CENTERS, INC. 1550 South Redwood Road Salt Lake City, Utah 84104 Attn: Mr. Casey Jones Director of Capital Development and Banking Gentlemen: We are pleased to confirm to you by this letter agreement (the "Agreement") that a new unsecured revolving credit facility has been placed at the disposal of SMITH'S FOOD & DRUG CENTERS, INC. (the "Company") for general corporate purposes under the following terms and conditions. This facility replaces the existing $15,000,000 revolving credit facility with Credit Suisse dated September 15, 1992. 1. THE REVOLVING CREDIT 1.1 Amount and General Terms: Subject to the terms hereof, we will make loans to the Company as you may request from time to time from the date hereof (the "Effective Date") to June 30, 1996 (the "Commitment Termination Date"), up to but not exceeding $15,000,000.00 in aggregate principal amount at any time outstanding (the "Commitment"). The Company may borrow, repay, and reborrow hereunder, from the date of its acceptance of this Agreement until the commitment Termination Date, either the full amount of the Commitment or any lesser sum which is $1,000,000 or a multiple thereof, by means of the borrowing options outlined below, provided that all loans will be repaid to us on the Commitment Termination Date. 1.2 Borrowing Options and Interest Rates: Interest on the principal balance of the loan, from time to time outstanding, will be payable at the Company's option at the following rates per annum: (a) For periods of one, two, three or six months, London Interbank Offered Rate (LIBOR) plus a margin of 50.0 basis points. (b) For periods of one to twenty-nine days, Credit Suisse Base Rate. "Base Rate" means the higher of (1) the base commercial lending rate announced by us from time to time or (2) the rate of interest quoted to us from time to time for the purchase by us from other banks or dealers of United States Federal Funds on an overnight basis in an amount comparable to the principal amount of the relevant loan plus 50 basis points. Any change in such Base Rate shall be effective on the date specified in the public announcement of such change. (c) For periods of one to twenty-nine days, bid option at negotiated rates. Interest is payable on the last business day of the interest period of the relevant borrowing and if such interest period is longer than three months, at intervals of three months after the first day thereof, and at a maturity of the relevant borrowing. Interest shall be computed on the actual number of days elapsed on a 360-day year basis. Overdue payments of principal and interest shall bear interest, payable on demand, at a rate equal to the Base Rate plus 1% per annum until paid in full. All borrowing under this Commitment will be evidenced by one Revolving Promissory Note (attached) duly executed by the Company. 1.3 Borrowing Notices, Payments and Prepayments: (a) Request for Base Rate borrowing and bid option should be made before 11:00 A.M. Los Angeles time on the date of such request. (b) Request for LIBOR borrowing should be made three business days prior to the intended drawing as it is customary that the rate applicable to the specific borrowing period be fixed two London business days preceding the date of borrowing. All loans will be paid free and clear of all taxes now imposed, or those that will affect any change in the basis of taxation of any amounts payable to the Bank (other than Federal, State and Local income taxes imposed on the Bank). Loans based on Base Rate may be prepaid without penalty. Prepayment of loans granted on a LIBOR basis will be subject to a prepayment penalty equal to the amount of any loss incurred by us in liquidating and/or re-employing the amounts borrowed by us to fund the loans, plus related reasonable expenses. 1.4 Commitment Fees. From and after the date hereof, until the Commitment Termination Date, the Company will pay us a commitment fee equal to 25.0 basis points per annum on the average daily undisbursed amount of the Commitment, from the Effective Date up to and including the Commitment Termination Date, payable quarterly in arrears, commencing on December 31, 1993. The commitment fee shall be calculated on the basis of actual days elapsed and a year of 360 days. All disbursements and payments hereunder are to be made in U.S. dollars in immediately available funds. All payments by or on behalf of the Company to us under this Agreement shall be made prior or 12:00 P.M. Los Angeles time on the date due to us at offices at 12 East 49th Street, New York, NY 10017 (Attn: Loan Department). 2. YIELD PROTECTION AND ILLEGALITY 2.1 Additional Costs. In the event that by reason of the provisions of Federal Reserve Board Regulation D as presently in effect or by reason of any amendment or change in said regulation or in any other applicable banking law or regulations or the interpretation thereof or by reason of any requirements or directives of any governmental authority whatsoever, we incur reserve costs on, or on account of, any advance or commitment, we shall inform the Company accordingly and shall from time to time charge the Company for such reserve costs. 2.2 Capital Adequacy. In addition, the Company agrees to pay us on demand such amounts as we reasonably determine are necessary to compensate us for any increased costs or reduction in rates of return attributable to this Agreement and resulting from the applications of any law, regulation, directive or request becoming effective after the date of this Agreement (regardless if earlier promulgated or announced) and applicable to the Bank regarding any reserve, assessment, capital adequacy or capital maintenance or similar requirement relating to this Agreement. 2.3 Illegality. Notwithstanding any other provision in this Agreement, in the event that it becomes unlawful for us to honor our obligations to make or maintain LIBOR loans hereunder, the we shall promptly notify the Company thereof and our obligation to make, maintain or to convert into LIBOR loans hereunder shall be suspended until such time as we may again make and maintain LIBOR loans. In such event, we shall make every effort to provide an alterative hereunder to such LIBOR loans which is reasonably comparable thereto. 3. REPRESENTATIONS AND WARRANTIES The Company hereby represents to us that: 3.1 Corporate Organization and Authority. (i) The Company has the power, authority and capacity to execute, deliver and perform this Agreement and all other documents executed in connection herewith and (ii) this Agreement and the documents executed in connection herewith constitute the valid and binding obligations of the Company and are enforceable in accordance with their respective terms. 3.2 Financial Condition. The Company represents and warrants that the financial statements of the Company dated March 31, 1991 furnished to the Bank fairly present the Company's financial position as of the date of such statements and the results of its operations and the changes in such financial position for the period then ended in accordance with generally accepted accounting principles consistently applied. As of the date of this Agreement and the date of any borrowing hereunder, the Company represents that no material adverse change has occurred since March 31, 1991, with respect to the ability of the Company to perform under this facility. The Company will furnish the Bank audited financial statements within 120 days after the closing of the Company's fiscal year, and unaudited financial statements within 60 days after the closing of each of the first three fiscal quarters. The Company will also provide any additional information as the Bank may reasonably request and will allow the Bank reasonable access to its books and records. Accompanying the annual financial statements, the Company will provide an opinion of an independent certified public accountant of recognized national standing, which opinion shall state that said consolidated financial statements fairly present the consolidated financial condition and results of operations of the Company as at the end of, and for, such fiscal year, and a certificate of such accountants stating that, in making the examination necessary for their opinion, they obtained no knowledge, except as specifically stated, of any Default. Promptly after the Company knows or has reason to know that any Default has occurred or any event which with notice or lapse of time or both would become an Event of Default, a notice of such Default describing the same in reasonable detail and, together with such notice or as soon thereafter as possible, a description of the action that the Company has taken and proposes to take with respect thereto; and The Company will furnish, at the time it furnishes each set of financial statements, a certificate of a senior financial officer of the Company (i) to the effect that no Default has occurred and is continuing (or, if any Default has occurred and is continuing, describing the same in reasonable detail and describing the action that the Company has taken and proposes to take with respect thereto) and (ii) setting forth in reasonable detail the computations necessary to determine whether the Company is in compliance with the covenants per 4.1. 3.3 Restriction on Fundamental Changes. The Company will not, and will not permit any of its subsidiaries to, enter into any transaction of merger or consolidation or liquidate, wind up or dissolve itself or convey, sell, lease, transfer or otherwise dispose of all or substantially all its assets to any other Person, except in the ordinary course of its business, provided that the Company may merge with another Person if (i) the Company is the corporation surviving such merger and (ii) immediately after giving effect to such merger, no Default shall have occurred and be continuing. 4 COVENANTS 4.1 Financial Covenants. The Company covenants and agrees that so long as this facility shall remain available, and until the full and final payment of all indebtedness incurred hereunder, it will, unless we waive compliance in writing: (a) Maintain a Fixed Charge Coverage ratio of not less than 1.5 to 1, measured at the end of each fiscal quarter. "Fixed Charge Coverage" means the sum of net income plus income taxes plus fixed charges (interest plus net rents) divided by fixed charges. (b) Maintain a Tangible Net Worth of not less than the sum of $400 million, plus 30% of net income after taxes on a quarterly basis, plus 100% of any increase in shareholder's equity other than the quarterly income increases, measured at the end of each fiscal quarter, commencing with the quarter ending September 30, 1992. (c) Maintain a Leverage Ratio not to exceed 2.0 to 1, measured at the of each fiscal quarter. As used herein, "Leverage Ratio" means the ratio of total debt to tangible net worth. Total debt includes all borrowed money and lease obligations (including capital leases and operating leases, the latter to be calculated as six times the annual amount owed.) 4.2 Negative Pledge. The Company will cause the payment obligations under this Agreement at all times to rank at least equally and rateably in all respects with all its other unsecured and unsubordinated indebtedness, and the Company will not, nor will it permit any of its subsidiaries to, create, incur, assume or suffer to exist any Lien upon any of its inventory, whether now owned or hereafter acquired, unless the benefit of the relevant security, or of alternative security satisfactory to us, is at the same time and in a manner satisfactory to us extended equally and rateably to the loans made and/or to be made and all other sums payable by the Company under this Agreement. 5. EVENTS OF DEFAULT In the event of any of the following defaults, the Bank may without presentment, demand, protest or notice of any kind, all of which are hereby expressly waived by the Company, declare the principal of all drawings plus accrued interest to be immediately due and payable and terminate this line of credit: 5.1 Failure to pay principal, interest or fees under this Agreement within 10 days after such becomes due. 5.2 Failure to comply with any other covenants or obligation in this Agreement for 30 days. 5.3 If any material representation made by the Company to us concerning the Company's business or financial condition shall prove to have been incorrect when made. 5.4 If the Company shall default in the performance or observance of any provision or covenant contained within any existing loan agreement other than this Agreement which the Company may have in effect with any other lender, other than to us, during the tenor of this Agreement, and such default shall continue unremedied for a period of 20 calendar days. 5.5 If the Company shall admit its inability to pay its debts as they mature, or shall make an assignment for the benefit of any of its creditors, or proceedings are instituted by or against the Company under any bankruptcy, reorganization or insolvency law or other law for the relief of debtors. 5.6 If the Company shall suffer final judgment for the payment of money aggregating in excess of US$5,000,000 and shall not discharge the same within a period of 30 days unless, pending further proceedings, execution has not been commenced or if commenced has been effectively stayed. 5.7 The Company shall fail to meet any of its obligations under the Employment Retirement Income Security Act of 1974 ("ERISA") or notice of a proceeding to terminate any "plan" under ERISA to appoint a trustee of a "plan" is not dismissed within 60 days of such notice. Upon the occurrence of any of the above listed events of default, we may, without prior notice, set off and apply any and all deposits maintained with us and any other indebtedness owing by us to the Company against any and all obligations of the Company hereunder. 6 EXPENSES The Company agrees to reimburse us for all out-of-pocket expenses that we may incur relating to any default, dispute or enforcement of these terms and conditions or of the Revolving Promissory Note, including reasonable attorneys' fees, and all costs of collection. The party prevailing with respect to any action brought by the other party with respect to the enforceability of this Agreement in any court of competent jurisdiction shall be reimbursed by the non-prevailing party for all reasonable costs and expenses, including reasonable attorney fees, with respect to this Agreement. 7. DOCUMENTATION Our obligation to extend credit under this line of credit is conditioned upon the receipt of all of the following documents, dated as of a recent date and in a form and substance satisfactory to us: - A certified copy of a Resolution of the Board of Directors of the Company authorizing the execution, delivery, and performance of all documents relative to the commitment contemplated herein, and the making of the credit. Such Resolution will be certified by the Secretary or any other appropriate officer of the Company. - A certified copy of the Articles of Incorporation and By-laws of the Company - Specimen Signature Records of the Company - Revolving Promissory Note (enclosed) 8. MISCELLANEOUS 8.1 This Agreement is governed by California law, and may not be amended except by instrument in writing signed by the Company and us. 8.2 We may assign, negotiate, pledge or otherwise hypothecate all or any portion of this Agreement, or grant participation herein or in any of our rights and security hereunder. 8.3 Nothing herein shall prohibit us from pledging or assigning the Revolving Promissory Note to any Federal Reserve Bank in accordance with applicable law. If the foregoing meets with your approval, please sign and return to us the enclosed copy of this letter agreement to signify your agreement with the terms and conditions stipulated therein. It is our pleasure to make this line available to you, and we look forward to a long and mutually satisfactory relationship. Very truly yours, CREDIT SUISSE David J. Worthington Edward Siegel Member of Senior Management Associate Credit Suisse Telephone No.: (213) 955-8200 800 Wilshire Blvd. Telex No.: 67227 Los Angeles, CA 90017 Telefax No. (213) 955-8245 Read, Agreed & Accepted: By: ______________________ Title: ___________________ SMITH'S FOOD & DRUG CENTERS, INC. Telephone No.: __________________________ Telex No.: __________________________ Telefax No.: __________________________ REVOLVING PROMISSORY NOTE October 15, 1993 US$15,000,000.00 FOR VALUE RECEIVED, SMITH'S FOOD & DRUG CENTERS, INC., a Delaware Corporation (the "Company"), hereby promises to pay to Credit Suisse, (the "Bank"), or order, at the office of the Bank at 12 East 49th Street, New York, N.Y. 10017 the principal sum of US$15,000,000 (USDOLLAR FIFTEEN MILLION) or such lesser amount as shall equal the aggregate unpaid principal amount of the loans made by the Bank to the Company under the letter agreement dated as of October 15, 1993 between the Company and the Bank (the "Agreement"), in lawful money of the United States of America and in immediately available funds, on the dates and in the amounts specified in the Agreement and to pay interest on the principal amount of each such loan, at such office, in like money and funds, for the period commencing on the date of such loan until such loan shall be paid in full, at the rates per annum and on the dates provided in the Agreement. The books and accounts of the Bank shall be conclusive evidence, absent manifest error, of the amounts of all loans, interest, fees and other charges advanced, due, outstanding or paid pursuant to the Agreement and this Note. This Note is the Revolving Promissory Note referred to in the Agreement under Section 1.2 and evidences loans made by the Bank thereunder. This Note is entitled to the benefits of the Agreement, which Agreement, among other things, contains provisions for acceleration of the maturity hereof upon the happening of certain stated events. This Note shall remain valid and in force despite the fact that there may be times when no indebtedness is owing hereunder. If payment is not made when due, then the unpaid principal and any accrued interest which are past due shall bear interest at the Bank's Base Rate (as defined in the Agreement) plus 1% per annum until paid in full. Presentment, demand, protest and diligence and notices of protest, dishonor and non-payment of this Note and all notices of every kind are hereby waived by the Company and each endorser, guarantor and surety of this Note. This Note shall be governed by and construed in accordance with the laws of the State of California. SMITH'S FOOD & DRUG CENTERS, INC. By: ______________________________ Its __________________________

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
6/30/96
Filed on:3/28/94
For Period End:1/1/94DEF 14A
12/31/93
10/15/93
9/30/92
9/15/92
 List all Filings 
Top
Filing Submission 0000850309-94-000003   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 8, 1:07:58.1pm ET